Recommendations for Use of p16/Ki67 Dual Stain for Management of Individuals Testing Positive for Human Papillomavirus: Erratum

No authors listed

Published Erratum

No authors listed. J Low Genit Tract Dis. 2024.

. 2024 Jul 1;28(3):316.

doi: 10.1097/LGT.0000000000000825.

No abstract available

Erratum for

Recommendations for Use of p16/Ki67 Dual Stain for Management of Individuals Testing Positive for Human Papillomavirus.
Clarke MA, Wentzensen N, Perkins RB, Garcia F, Arrindell D, Chelmow D, Cheung LC, Darragh TM, Egemen D, Guido R, Huh W, Locke A, Lorey TS, Nayar R, Risley C, Saslow D, Smith RA, Unger ER, Massad LS; Enduring Consensus Cervical Cancer Screening and Management Guidelines Committee. Clarke MA, et al. J Low Genit Tract Dis. 2024 Apr 1;28(2):124-130. doi: 10.1097/LGT.0000000000000802. Epub 2024 Mar 2. J Low Genit Tract Dis. 2024. PMID: 38446575 Free PMC article.

1. Clarke MA, Wentzensen N, Perkins RB, et al. Recommendations for Use of p16/Ki67 Dual Stain for Management of Individuals Testing Positive for Human Papillomavirus. J Lower Genit Tract Dis 2024;28:124–30.